Home
>
Strides Pharma Science Ltd Financials

Strides Pharma Science Ltd Financial Statement

Strides Pharma Science Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

(Rs. CR)	Dec 2023	Sep 2023	Jun 2023
Revenue	528.7	562.63	486.97
Operating Expense	459.65	497.02	419.76
Net Profit	2.54	1.28	8
Net Profit Margin	0.48	0.23	1.64
Earning Per Share	0.28	0.14	0.89
EBIDTA	68.75	65.48	65.76
Effective Tax Rate	0.98	4.25	-0.49

(Rs. Cr)

Revenue

Operating Expense

Net Profit

Net Profit Margin

Earning Per Share

EBIDTA

Effective Tax Rate

528.7

459.65

2.54

0.48

0.28

68.75

0.98

562.63

497.02

1.28

0.23

0.14

65.48

4.25

486.97

419.76

1.64

0.89

65.76

-0.49

Strides Pharma Science Ltd Profit & Loss

*All values are in Rs. Cr

Consolidated

Standalone

Particulars	Mar 2023	Mar 2022	Mar 2021
Total Revenue Annual	3,688.39	3,070.25	3,315.87
Operating Expenses Annual	3,258.21	3,090.36	2,681.04
Operating Profit Annual	236.76	-242.76	645.73
Interest Annual	261.14	176.74	150.07
Depreciation	138.17	144.97	122.19
Net Profit Annual	-221.2	-460.21	254.5
Tax Annual	-55.3	-178.26	31.65

Particulars

Total Revenue Annual

Operating Expenses Annual

Operating Profit Annual

Interest Annual

Depreciation

Net Profit Annual

Tax Annual

3,688.39

3,258.21

236.76

261.14

138.17

-221.2

-55.3

3,070.25

3,090.36

-242.76

176.74

144.97

-460.21

-178.26

3,315.87

2,681.04

645.73

150.07

122.19

254.5

31.65

Strides Pharma Science Ltd Cash Flow

*All values are in Rs. Cr

Consolidated

Standalone

Particulars	Mar 2023	Mar 2022	Mar 2021
Cash Flow at the Beginning	170.73	125.83	182.23
Cash Flow from Operations	44.41	-257.82	481.44
Cash Flow from Investing	302.28	-118.61	-522.04
Cash Flow from Financing	-213.92	421.32	-15.8
Cash Flow at the End	303.5	170.73	125.83

Particulars

Cash Flow at the Beginning

Cash Flow from Operations

Cash Flow from Investing

Cash Flow from Financing

Cash Flow at the End

170.73

44.41

302.28

-213.92

303.5

125.83

-257.82

-118.61

421.32

170.73

182.23

481.44

-522.04

-15.8

125.83

Strides Pharma Science Ltd Key Ratios

*All values are in Rs. Cr

Consolidated

Standalone

Particulars	Mar 2023	Mar 2022	Mar 2021
PBDIT Margin (%)	6.42	-0.34	18.06
PBIT Margin (%)	-0.18	-7.93	11.84
PBT Margin (%)	-0.18	-7.86	11.7
Net PROFIT Margin (%)	0.25	9.11	4.21
Return On Networth / Equity (%)	TBA	-9.42	8.14
Return On Networth /Employed(%)	TBA	-4.44	7.59
Return On Assets (%)	0.17	5.1	2.65
Total Debt / Equity(X)	0.39	0.33	0.28
Asset Turnover Ratio (%)	0.68	0.56	0.63

Particulars

PBDIT Margin (%)

PBIT Margin (%)

PBT Margin (%)

Net PROFIT Margin (%)

Return On Networth / Equity (%)

Return On Networth / Employed(%)

Return On Assets (%)

Total Debt / Equity(X)

Asset Turnover Ratio (%)

6.42

-0.18

0.25

TBA

0.17

0.39

0.68

-0.34

-7.93

-7.86

9.11

-9.42

-4.44

5.1

0.33

0.56

18.06

11.84

11.7

4.21

8.14

7.59

2.65

0.28

0.63

Strides Pharma Science Ltd Balance Sheet

*All values are in Rs. Cr

Consolidated

Standalone

Particulars	Mar 2023	Mar 2022	Mar 2021
Fixed Assets Annual	2,401.14	2,568.3	2,370.9
Total Current Assets Annual	3,243.36	3,361.83	2,817.23
Non Current Assets Annual	3,395.06	3,614.03	4,197.79
Total Shareholders Funds Annual	2,212.26	2,359.23	2,776.66
Total Assets Annual	6,638.42	6,975.86	7,015.02

Particulars

Fixed Assets Annual

Total Current Assets Annual

Non Current Assets Annual

Total Shareholders Funds Annual

Total Assets Annual

2,401.14

3,243.36

3,395.06

2,212.26

6,638.42

2,568.3

3,361.83

3,614.03

2,359.23

6,975.86

2,370.9

2,817.23

4,197.79

2,776.66

7,015.02

Strides Pharma Science Ltd Earning Calls

Dec 2023

EPS beaten by 0.37 %

Open Demat Account

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

Dividend Pages

Get Your FAQs Right

What is Strides Pharma Science Ltd's share capital?

As of May 20, 2024, Strides Pharma Science Ltd has a market capitalization of 2,584.01 Cr. Value Research classifies it as a Mid-Cap company.

Is Strides Pharma Science Ltd debt-free?

No, Strides Pharma Science Ltd is not debt-free with a debt-to-equity ratio of 1.37.

What is Strides Pharma Science Ltd's total revenue?

In FY 2023, Strides Pharma Science Ltd recorded a total revenue of approximately 3,688.39 Cr marking a significant milestone in the company's financial performance.

What is the future growth of Strides Pharma Science Ltd?

Strides Pharma Science Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.5% and 0.1% annually, respectively..

What is the PE Ratio of Strides Pharma Science Ltd?

Strides Pharma Science Ltd's current PE ratio is -12.75.

What is Strides Pharma Science Ltd's Return on Capital Employed (ROCE)?

Strides Pharma Science Ltd's ROCE averaged 1.0% from the FY ending March 2021 to 2023, with a median of -0.1%. It peaked at 7.4% in March 2021, reflecting strong capital efficiency over the period..

What is the latest EBIT (Earnings Before Interest and Taxes) of Strides Pharma Science Ltd?

Strides Pharma Science Ltd's latest EBIT is Rs. -6.49 Cr, surpassing the average EBIT of Rs. -14.27 Cr over the 5 years..